Aripiprazole API Powder

Aripiprazole is an atypical antipsychotic orally indicated for the treatment of schizophrenia, bipolar I, major depressive disorder, irritability associated with autism, and Tourette's. It is also indicated as an injection for agitation associated with schizophrenia or bipolar mania. About the Company GST Registration Date: 2024 Legal Status of Firm: Partnership Number of Employees: 11 To 25 People Annual Turnover: 1.5 - 5 Cr company-description: Gathi Lifesciences is a dynamic and growing partnership firm established in 2024 in the thriving pharmaceutical hub of Telangana, India. We specialize in the trading and distribution of high-quality API Intermediates-key raw materials used in the production of pharmaceutical drugs. Our operations are rooted in the commitment to providing reliable, cost-effective solutions to our clients in the pharmaceutical, biotech, and healthcare industries. As a trusted partner, Gathi Lifesciences ensures that all our products meet the highest standards of quality and regulatory compliance. Our firm leverages cutting-edge logistics, robust supply chain management, and a deep understanding of global markets to deliver timely and efficient services. Positioned strategically in Telangana, we are at the heart of one of India's largest pharmaceutical manufacturing ecosystems, allowing us to serve both domestic and international clients with precision and care.